Clinical Trial Update: An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol [Phase 2]

View source ↗

Summary

An open-label Phase 2 extension study evaluated possible drug-drug interactions between clobazam and cannabidiol in epilepsy patients; completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• CLOBAZAM (CLOBAZAM)
• Cannabidiol (cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2018-09-11